John Mcgee

John McGee is a highly accomplished scientist with extensive experience in biochemistry and drug discovery. Currently serving as the Scientific Founder and Head of De Novo Discovery at FogPharma since 2016, John has been instrumental in advancing innovative therapeutic approaches. Prior to this role, John was a Postdoctoral Fellow at Harvard University from 2013 to 2016. John earned a PhD in Biochemistry from Harvard University in 2013, following a Bachelor of Science in Chemistry from Stanford University in 2008.